NFE2L2 and ischemic stroke: In a recent study in an animal model of transient middle cerebral artery occlusion, LA treatment was neuroprotective and promoted functional recovery after ischemic stroke by attenuating oxidative damage, which was partially mediated by the NRF2/HO-1 pathway [22].